{
  "meta": {
    "id": "test54",
    "title": "Mid Day Module (OBG-1) - 2025-03-02",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 30-year-old primigravida woman presents at 29 weeks gestation with headache and a blood pressure of 160/110 mm Hg. Investigations reveal 2+ proteinuria on dipstick, an elevated SGOT and SGPT and a platelet count of 80,000/mm 3 . What is the best management?",
      "options": [
        {
          "label": "A",
          "text": "Oral antihypertensive therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Platelet transfusion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Magnesium sulphate therapy and induction of labour",
          "correct": true
        },
        {
          "label": "D",
          "text": "Intravenous immunoglobulin therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Magnesium sulphate therapy and induction of labour",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-134609.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Magnesium sulphate therapy and induction of labour</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 1852, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1852, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e80f53bc",
      "audio": ""
    },
    {
      "text": "A 20-year primi presented at 32 weeks with eclampsia. She was started on MgSO4 (Pritchard\u2019s regime) and she delivered after induction of labor. Maintenance dose of MgSO4 was continued for 24 hours. Prevention of Mg toxicity involves monitoring of the following clinical parameters:",
      "options": [
        {
          "label": "A",
          "text": "Deep tendon reflexes, urine output, Respiratory rate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Deep tendon reflexes, O2 saturation, consciousness status",
          "correct": false
        },
        {
          "label": "C",
          "text": "O2 saturation, urine output, heart rate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Heart rate, BP, respiratory rate and urine output",
          "correct": false
        }
      ],
      "correct_answer": "A. Deep tendon reflexes, urine output, Respiratory rate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Deep tendon reflexes, urine output, Respiratory rate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The prevention of magnesium toxicity in the management of eclampsia involves careful monitoring of deep tendon reflexes, urine output, and respiratory rate. Deep tendon reflexes help detect early signs of toxicity, urine output indicates renal function and magnesium clearance, and respiratory rate assesses potential respiratory depression from magnesium sulfate.</li><li>\u27a4 Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li><li>\u27a4 Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "555cca9d",
      "audio": ""
    },
    {
      "text": "A 22-year Primigravida presents at 34 weeks to the emergency with a BP of 160/110 mmHg. Her urine albumin is 3 +. She is complaining of headache and blurring of vision. On examination, the fetal heart cannot be auscultated. The uterus is relaxed, and a vaginal examination reveals a soft cervix which is 1 cm dilated and 30% effaced. You administer IV labetalol to lower her BP. What is the best immediate next line of management?",
      "options": [
        {
          "label": "A",
          "text": "Emergency Cesarean section.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Induction of labor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prophylactic MgSO4",
          "correct": true
        },
        {
          "label": "D",
          "text": "Urgent Ultrasound to see the fetal status",
          "correct": false
        }
      ],
      "correct_answer": "C. Prophylactic MgSO4",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Prophylactic MgSO4</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Management of Preeclampsia: Definitive treatment is delivery Mild preeclampsia: Termination at 37 weeks Severe preeclampsia Admit; Consider prophylactic MgSO4 Start anti-hypertensives Terminate at 37 weeks or SOS if Persistent severe HTN Eclampsia, HELLP, pulmonary edema, ARF, DIC Fetal compromise Abruption Pre-viable fetus Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if < 34 weeks</li><li>\u27a4 Management of Preeclampsia:</li><li>\u27a4 Definitive treatment is delivery</li><li>\u27a4 Mild preeclampsia: Termination at 37 weeks</li><li>\u27a4 Severe preeclampsia Admit; Consider prophylactic MgSO4 Start anti-hypertensives Terminate at 37 weeks or SOS if Persistent severe HTN Eclampsia, HELLP, pulmonary edema, ARF, DIC Fetal compromise Abruption Pre-viable fetus</li><li>\u27a4 Admit; Consider prophylactic MgSO4 Start anti-hypertensives Terminate at 37 weeks or SOS if Persistent severe HTN Eclampsia, HELLP, pulmonary edema, ARF, DIC Fetal compromise Abruption Pre-viable fetus</li><li>\u27a4 Admit; Consider prophylactic MgSO4</li><li>\u27a4 Start anti-hypertensives</li><li>\u27a4 Terminate at 37 weeks or SOS if Persistent severe HTN</li><li>\u27a4 Persistent severe HTN</li><li>\u27a4 Persistent severe HTN</li><li>\u27a4 Eclampsia, HELLP, pulmonary edema, ARF, DIC</li><li>\u27a4 Fetal compromise</li><li>\u27a4 Abruption</li><li>\u27a4 Pre-viable fetus</li><li>\u27a4 Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if < 34 weeks</li><li>\u27a4 Ref: Page no 732, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 732, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dcac8bc8",
      "audio": ""
    },
    {
      "text": "Which is NOT an indication of using this drug in obstetrics?",
      "options": [
        {
          "label": "A",
          "text": "Neuroprotection in preterm labor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Severe preeclampsia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tocolysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Severe IUGR",
          "correct": true
        }
      ],
      "correct_answer": "D. Severe IUGR",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Severe IUGR</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 MgSO4 is used for the following obstetric indications.</li><li>\u27a4 Eclampsia & severe preeclampsia As a tocolytic in preterm labor For neuroprotection in very preterm</li><li>\u27a4 Eclampsia & severe preeclampsia</li><li>\u27a4 As a tocolytic in preterm labor</li><li>\u27a4 For neuroprotection in very preterm</li><li>\u27a4 Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li><li>\u27a4 Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "66f244ee",
      "audio": ""
    },
    {
      "text": "All are true regarding predictive tests for preeclampsia except?",
      "options": [
        {
          "label": "A",
          "text": "An exaggerated diastolic notch is seen beyond 24 weeks on uterine artery Doppler in women at risk for developing pre-eclampsia.",
          "correct": false
        },
        {
          "label": "B",
          "text": "A drop in levels of PAPP-A and PlGF is a predictor for preeclampsia.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cell free DNA is increased in women who are at risk of developing preeclampsia due to accelerated apoptosis of cytotrophoblasts",
          "correct": false
        }
      ],
      "correct_answer": "C. Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-185956.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-190116.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Predictors of preeclampsia:</li><li>\u27a4 Predictors of preeclampsia:</li><li>\u27a4 Biophysical markers : Raised PI in the uterine Artery (11 \u2013 14 weeks); notching of uterine Artery waveform (mid trimester). Biochemical markers:</li><li>\u27a4 Biophysical markers : Raised PI in the uterine Artery (11 \u2013 14 weeks); notching of uterine Artery waveform (mid trimester).</li><li>\u27a4 Biophysical markers</li><li>\u27a4 Biochemical markers:</li><li>\u27a4 Biochemical markers:</li><li>\u27a4 S-Flt-1 and s-Eng are Anti-angiogenic factors (Not angiogenic) Roll over test : 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test \u2013 30% of such women will develop pre-eclampsia in the future. This test is not done anymore. Angiotensin II sensitivity test : Rise in BP with Angiotensin II infusion.</li><li>\u27a4 S-Flt-1 and s-Eng are Anti-angiogenic factors (Not angiogenic)</li><li>\u27a4 Anti-angiogenic factors (Not angiogenic)</li><li>\u27a4 Roll over test : 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test \u2013 30% of such women will develop pre-eclampsia in the future. This test is not done anymore.</li><li>\u27a4 Roll over test</li><li>\u27a4 Angiotensin II sensitivity test : Rise in BP with Angiotensin II infusion.</li><li>\u27a4 Angiotensin II sensitivity test</li><li>\u27a4 Ref: Page no 1818, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1818, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "42283087",
      "audio": ""
    },
    {
      "text": "A 35-year primigravida is worried about her risk of developing preeclampsia. What intervention would help reduce the risk in her?",
      "options": [
        {
          "label": "A",
          "text": "Low salt diet",
          "correct": false
        },
        {
          "label": "B",
          "text": "Calcium supplementation started prior to 12 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspirin 150 mg/ day prior to 16 weeks",
          "correct": true
        },
        {
          "label": "D",
          "text": "Antioxidants \u2013 ascorbic acid and \u03b1-tocopherol prior to 12 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. Aspirin 150 mg/ day prior to 16 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Aspirin 150 mg/ day prior to 16 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Low-dose aspirin started before 16 weeks of gestation is a recommended intervention to reduce the risk of developing preeclampsia, particularly for women at high risk.</li><li>\u27a4 Low-dose aspirin started before 16 weeks of gestation is a recommended intervention to reduce the risk of developing preeclampsia, particularly for women at high risk.</li><li>\u27a4 Ref: Page no 1825, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1825, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "38845bb1",
      "audio": ""
    },
    {
      "text": "Anti-hypertensives contra-indicated in pregnancy are all except?",
      "options": [
        {
          "label": "A",
          "text": "Alpha-methyldopa",
          "correct": true
        },
        {
          "label": "B",
          "text": "Captopril",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enalapril",
          "correct": false
        },
        {
          "label": "D",
          "text": "Losartan",
          "correct": false
        }
      ],
      "correct_answer": "A. Alpha-methyldopa",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Alpha-methyldopa</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The anti-hypertensive drug of choice in pregnancy is labetalol Alpha-methyldopa is considered safe and is one of the preferred anti hypertensives in pregnancy. However, ACE inhibitors (like captopril and enalapril) and ARBs (like losartan) are contraindicated due to their potential adverse effects on the developing fetus.</li><li>\u27a4 The anti-hypertensive drug of choice in pregnancy is labetalol</li><li>\u27a4 Alpha-methyldopa is considered safe and is one of the preferred anti hypertensives in pregnancy.</li><li>\u27a4 However, ACE inhibitors (like captopril and enalapril) and ARBs (like losartan) are contraindicated due to their potential adverse effects on the developing fetus.</li><li>\u27a4 Ref: Page no 438, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 438, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a3ea7f9",
      "audio": ""
    },
    {
      "text": "All are regimes of MgSO4 for treatment of eclampsia except?",
      "options": [
        {
          "label": "A",
          "text": "Dhaka regime",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sibai regime",
          "correct": false
        },
        {
          "label": "C",
          "text": "Magpie regime",
          "correct": true
        },
        {
          "label": "D",
          "text": "Zuspan regime",
          "correct": false
        }
      ],
      "correct_answer": "C. Magpie regime",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Magpie regime</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The key educational takeaway is that while there are several recognized regimens for the administration of magnesium sulfate in the management of eclampsia (like the Dhaka, Sibai, and Zuspan regimens), the \"Magpie regime\" is not one of them. Instead, the Magpie Trial was a significant research study that helped establish the effectiveness of magnesium sulfate in this context.</li><li>\u27a4 The key educational takeaway is that while there are several recognized regimens for the administration of magnesium sulfate in the management of eclampsia (like the Dhaka, Sibai, and Zuspan regimens), the \"Magpie regime\" is not one of them.</li><li>\u27a4 Instead, the Magpie Trial was a significant research study that helped establish the effectiveness of magnesium sulfate in this context.</li><li>\u27a4 Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li><li>\u27a4 Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ba39563",
      "audio": ""
    },
    {
      "text": "A 32-year-old primigravida at 39 weeks has a BP recording of 150/100 which when repeated is the same. Her baseline BP during earlier visits was 120/80 mmHg. She does not complain of headache/ blurring of vision or epigastric pain. Abdominal exam reveals a term uterus with cephalic presentation and FHR of 140 bpm. Urine albumin is nil. Which is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Preeclampsia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic hypertension with superimposed preeclampsia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Eclampsia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gestational hypertension",
          "correct": true
        }
      ],
      "correct_answer": "D. Gestational hypertension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Gestational hypertension</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: page 1780, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: page 1780, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "286a095f",
      "audio": ""
    },
    {
      "text": "Which of the following is not a part of HELLP syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Hemolysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated liver enzymes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thrombocytopenia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Retroplacental hemorrhage",
          "correct": true
        }
      ],
      "correct_answer": "D. Retroplacental hemorrhage",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Retroplacental hemorrhage</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 HELLP Syndrome</li><li>\u27a4 HELLP Syndrome</li><li>\u27a4 It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of < 1,00,000/mm 3 It is a rare complication of pregnancy induced hypertension. It may be associated even with mild hypertension and proteinuria</li><li>\u27a4 It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of < 1,00,000/mm 3</li><li>\u27a4 It is a rare complication of pregnancy induced hypertension.</li><li>\u27a4 It may be associated even with mild hypertension and proteinuria</li><li>\u27a4 Ref: Page no 1849, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1849, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6962b606",
      "audio": ""
    },
    {
      "text": "A Primigravida presents at 32 weeks with pre-eclampsia. She complains of decreased fetal movements. An umbilical artery Doppler is done which is as shown in the image. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Conservative management with anti-hypertensives",
          "correct": false
        },
        {
          "label": "B",
          "text": "Delivery after 34 weeks of gestation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immediate delivery",
          "correct": true
        },
        {
          "label": "D",
          "text": "Declare fetal demise",
          "correct": false
        }
      ],
      "correct_answer": "C. Immediate delivery",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture3.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Immediate delivery</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e8f5872",
      "audio": ""
    },
    {
      "text": "Which of the following are feature(s) of magnesium toxicity in pregnancy? Loss of deep tendon reflex Decreased respiratory rate Decreased urine output Hypertension Increased heart rate",
      "options": [
        {
          "label": "A",
          "text": "a, b, c",
          "correct": false
        },
        {
          "label": "B",
          "text": "a, d, e",
          "correct": false
        },
        {
          "label": "C",
          "text": "a, b",
          "correct": true
        },
        {
          "label": "D",
          "text": "a, b, c, d",
          "correct": false
        }
      ],
      "correct_answer": "C. a, b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. a, b</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Features of Magnesium Toxicity:</li><li>\u27a4 Features of Magnesium Toxicity:</li><li>\u27a4 Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign Decreased respiratory rate (<12 per minute) Chest pain, heart block, pulmonary edema Cardiac arrest O 2 saturation monitoring (PaO2 < 95%) Double vision Slurred speech Nausea-vomiting Muscular weakness</li><li>\u27a4 Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign</li><li>\u27a4 Decreased respiratory rate (<12 per minute)</li><li>\u27a4 Chest pain, heart block, pulmonary edema</li><li>\u27a4 Cardiac arrest</li><li>\u27a4 O 2 saturation monitoring (PaO2 < 95%)</li><li>\u27a4 Double vision</li><li>\u27a4 Slurred speech</li><li>\u27a4 Nausea-vomiting</li><li>\u27a4 Muscular weakness</li><li>\u27a4 **Decreased urine output is not a feature of Mg toxicity. Renal failure can be seen in severe preeclampsia/ eclampsia and as Mg is excreted through the kidneys, decreased renal function can increase the Mg levels in the blood thereby leading to Mg toxicity.</li><li>\u27a4 Ref: Page no 1880, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1880, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10d35141",
      "audio": ""
    },
    {
      "text": "A 34-year Primigravida presents to the antenatal OPD. Her mother is a diabetic and she is screened for Diabetes at her 8 weeks antenatal visit. What was the most likely screening method used?",
      "options": [
        {
          "label": "A",
          "text": "FBS & PPBS",
          "correct": false
        },
        {
          "label": "B",
          "text": "HBA1C",
          "correct": true
        },
        {
          "label": "C",
          "text": "Urine routine for sugar",
          "correct": false
        },
        {
          "label": "D",
          "text": "GCT",
          "correct": false
        }
      ],
      "correct_answer": "B. HBA1C",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. HBA1C</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective (Summary):</li><li>\u27a4 Hemoglobin A1C (HBA1C) is the most likely screening method used for diabetes at the 8-week antenatal visit, especially when there is a family history of diabetes. It provides a longer-term view of blood sugar control.</li><li>\u27a4 Ref: Page 1108, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 1108, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "70674144",
      "audio": ""
    },
    {
      "text": "An infant was born at 36 weeks of pregnancy with a birthweight 4.5 kg as shown in the image. Which of the following conditions is associated with this presentation?",
      "options": [
        {
          "label": "A",
          "text": "Anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Antepartum hemorrhage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gestational Diabetes mellitus",
          "correct": true
        },
        {
          "label": "D",
          "text": "Thrombocytopenia",
          "correct": false
        }
      ],
      "correct_answer": "C. Gestational Diabetes mellitus",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture13_fMnCKOd.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Gestational Diabetes mellitus</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The birth of an infant with a birthweight of 4.5 kg at 36 weeks of pregnancy is suggestive of macrosomia. Macrosomia is commonly associated with maternal gestational diabetes mellitus (GDM), which can lead to larger birthweights in babies.</li><li>\u27a4 The birth of an infant with a birthweight of 4.5 kg at 36 weeks of pregnancy is suggestive of macrosomia.</li><li>\u27a4 Macrosomia is commonly associated with maternal gestational diabetes mellitus (GDM), which can lead to larger birthweights in babies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "611f446e",
      "audio": ""
    },
    {
      "text": "For diagnosis of overt gestational diabetes, the fasting blood sugar (FBS] level should be?",
      "options": [
        {
          "label": "A",
          "text": "\u2265 110 mg/dl",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2265 126 mg/dl",
          "correct": true
        },
        {
          "label": "C",
          "text": "\u2265 140 mg/dl",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u2265 200 mg/dl",
          "correct": false
        }
      ],
      "correct_answer": "B. \u2265 126 mg/dl",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-200643.jpg"
      ],
      "explanation": "<p><strong>Ans. B. \u2265 126 mg/dl</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 To diagnose overt gestational diabetes, the fasting blood sugar (FBS) level should be \u2265 126 mg/dl (milligrams per decilitre).</li><li>\u27a4 To diagnose overt gestational diabetes, the fasting blood sugar (FBS) level should be \u2265 126 mg/dl (milligrams per decilitre).</li><li>\u27a4 It's important to note that the diagnostic criteria for gestational diabetes may vary in different guidelines and regions. However, a fasting blood sugar level of \u2265 126 mg/dl is a commonly recognized threshold for diagnosing overt gestational diabetes.</li><li>\u27a4 It's important to note that the diagnostic criteria for gestational diabetes may vary in different guidelines and regions. However, a fasting blood sugar level of \u2265 126 mg/dl is a commonly recognized threshold for diagnosing overt gestational diabetes.</li><li>\u27a4 Ref: Page 1108, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 1108, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "771228bb",
      "audio": ""
    },
    {
      "text": "A 34-year Primi who is a known diabetic on insulin presents at 34 weeks pregnancy. On examination, the uterus is 34 weeks and FHR is 140 bpm. Her blood sugar is well controlled. At what period of gestation should her delivery be planned?",
      "options": [
        {
          "label": "A",
          "text": "34 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "37 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "38 weeks",
          "correct": true
        },
        {
          "label": "D",
          "text": "40 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. 38 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 38 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In Overt Diabetes (Pre-gestational diabetes) on insulin, delivery is planned at 38 weeks. Earlier delivery may be planned if there are poorly controlled sugars or non-reassuring fetal status</li><li>\u27a4 In Overt Diabetes (Pre-gestational diabetes) on insulin, delivery is planned at 38 weeks.</li><li>\u27a4 Earlier delivery may be planned if there are poorly controlled sugars or non-reassuring fetal status</li><li>\u27a4 Ref: Page no 1107, Williams Obstetrics, Page no 509, Textbook of Obstetrics by JB Dutta</li><li>\u27a4 Ref: Page no 1107, Williams Obstetrics, Page no 509, Textbook of Obstetrics by JB Dutta</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba6c8ae1",
      "audio": ""
    },
    {
      "text": "All are true regarding physiology of pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Insulin secretion increases in pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insulin resistance is due to placental hormones",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maternal insulin can cross the placenta",
          "correct": true
        },
        {
          "label": "D",
          "text": "The fetus starts secreting insulin at 12 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. Maternal insulin can cross the placenta",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Maternal insulin can cross the placenta</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In pregnancy, there is an increase in insulin secretion due to increased insulin resistance, largely driven by placental hormones. However, maternal insulin does not cross the placenta; the fetus produces its own insulin in response to glucose that crosses from the maternal circulation.</li><li>\u27a4 Ref: Page 66, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 66, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8086feb7",
      "audio": ""
    },
    {
      "text": "Identify the maternal condition that can lead to the findings in the baby as shown below",
      "options": [
        {
          "label": "A",
          "text": "Pre-gestational diabetes",
          "correct": true
        },
        {
          "label": "B",
          "text": "Gestational diabetes mellitus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Effect of valproate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypertensive on ACE inhibitors",
          "correct": false
        }
      ],
      "correct_answer": "A. Pre-gestational diabetes",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture14_kY8nI7M.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Pre-gestational diabetes</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mermaid syndrome or sirenomelia is characteristically associated with overt (pre-gestational) Diabetes mellitus. The most common anomaly associated with pre-gestational diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</li><li>\u27a4 Mermaid syndrome or sirenomelia is characteristically associated with overt (pre-gestational) Diabetes mellitus.</li><li>\u27a4 The most common anomaly associated with pre-gestational diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</li><li>\u27a4 Ref: Page 1110, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 1110, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d8386d9",
      "audio": ""
    },
    {
      "text": "Which hypoglycemic drug cannot be used in diabetes in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Glyburide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insulin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metformin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pioglitazone",
          "correct": true
        }
      ],
      "correct_answer": "D. Pioglitazone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Pioglitazone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 When treating diabetes in pregnancy, insulin is the preferred medication due to its safety profile. Metformin and glyburide can also be used, albeit with some caution and monitoring. Pioglitazone, on the other hand, is not recommended for use during pregnancy due to the lack of sufficient safety data and potential fetal risks.</li><li>\u27a4 When treating diabetes in pregnancy, insulin is the preferred medication due to its safety profile.</li><li>\u27a4 Metformin and glyburide can also be used, albeit with some caution and monitoring.</li><li>\u27a4 Pioglitazone, on the other hand, is not recommended for use during pregnancy due to the lack of sufficient safety data and potential fetal risks.</li><li>\u27a4 Ref: Page no 1110, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 1110, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0f1650f7",
      "audio": ""
    },
    {
      "text": "A 32-years old G3P2L2 visits an antenatal clinic at 28 weeks. She reveals during history that her first baby weighed 4.6 kg, second baby weighed 4.8 kg, and both were delivered by C-section. Neonatal complications of an infant of diabetic mother except?",
      "options": [
        {
          "label": "A",
          "text": "Necrotizing enterocolitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperbilirubinemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Neonatal hypocalcemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Neonatal hyperglycemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Neonatal hyperglycemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.\u00a0 Neonatal hyperglycemia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Neonatal complications (Seen because of Pedersen Hypothesis)</li><li>\u27a4 Hypoglycemia Respiratory distress syndrome Hyperbilirubinemia Necrotizing enterocolitis Polycythemia Hypocalcemia Hypomagnesemia Cardiomyopathy</li><li>\u27a4 Hypoglycemia</li><li>\u27a4 Respiratory distress syndrome</li><li>\u27a4 Hyperbilirubinemia</li><li>\u27a4 Necrotizing enterocolitis</li><li>\u27a4 Polycythemia</li><li>\u27a4 Hypocalcemia</li><li>\u27a4 Hypomagnesemia</li><li>\u27a4 Cardiomyopathy</li><li>\u27a4 Ref: Page no 1102, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 1102, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "46b03e92",
      "audio": ""
    },
    {
      "text": "A pregnant woman in her second trimester presents with mildly elevated liver enzymes and itching over her body. She has no history of liver disease. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute fatty liver of pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "HELLP syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intrahepatic cholestasis of pregnancy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acute viral hepatitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Intrahepatic cholestasis of pregnancy",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-125402.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Intrahepatic cholestasis of pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Acute Fatty Liver of Pregnancy: This is diagnosed by the Swansea criteria. Patients with AFLP usually present in the 3 rd trimester with jaundice, abdominal pain, vomiting. There is altered liver function along with worsening renal and coagulation parameters. Hypoglycemia is typically seen. Option B: HELLP Syndrome: This is a form of severe preeclampsia so a h/o high BP would usually be mentioned. HELLP syndrome is a triad of H emolysis, E levated L iver Enzymes and L ow P latelets. Option D: Acute viral hepatitis: This can be seen in any trimester. There is a history of fever, constitutional symptoms and jaundice. Serum bilirubin is raised and AST and ALT are very highly raised.</li><li>\u2022 Option A: Acute Fatty Liver of Pregnancy: This is diagnosed by the Swansea criteria. Patients with AFLP usually present in the 3 rd trimester with jaundice, abdominal pain, vomiting. There is altered liver function along with worsening renal and coagulation parameters. Hypoglycemia is typically seen.</li><li>\u2022 Option A: Acute Fatty Liver of Pregnancy:</li><li>\u2022 Option B: HELLP Syndrome: This is a form of severe preeclampsia so a h/o high BP would usually be mentioned. HELLP syndrome is a triad of H emolysis, E levated L iver Enzymes and L ow P latelets.</li><li>\u2022 Option B: HELLP Syndrome:</li><li>\u2022 H</li><li>\u2022 E</li><li>\u2022 L</li><li>\u2022 L</li><li>\u2022 P</li><li>\u2022 Option D: Acute viral hepatitis: This can be seen in any trimester. There is a history of fever, constitutional symptoms and jaundice. Serum bilirubin is raised and AST and ALT are very highly raised.</li><li>\u2022 Option D: Acute viral hepatitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference- Page no 270, DC Dutta\u2019s textbook of Obstetrics, 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "760a9705",
      "audio": ""
    },
    {
      "text": "Which of the following is true about Acute fatty liver of pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "It is associated with high fetal and maternal morbidity and mortality",
          "correct": true
        },
        {
          "label": "B",
          "text": "Commonly occurs in the 2 nd trimester",
          "correct": false
        },
        {
          "label": "C",
          "text": "It has an association with gestational diabetes mellitus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Less common in multiple pregnancies",
          "correct": false
        }
      ],
      "correct_answer": "A. It is associated with high fetal and maternal morbidity and mortality",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/screenshot-2023-04-30-144450.jpg"
      ],
      "explanation": "<p><strong>Ans. A. It is associated with high fetal and maternal morbidity and mortality</strong></p>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference- Williams Obstetrics 25 th edition, Page no 1061</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "806e569d",
      "audio": ""
    },
    {
      "text": "Which is not seen in pregnancy regarding renal changes in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Kidney increases in pregnancy by about 1.5 cm",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pelvicalyceal dilatation is more on the left side than the right side",
          "correct": true
        },
        {
          "label": "C",
          "text": "An increased GFR leads to lower serum creatinine levels",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glycosuria may be seen in up to 50% of pregnant women",
          "correct": false
        }
      ],
      "correct_answer": "B. Pelvicalyceal dilatation is more on the left side than the right side",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.\u00a0 Pelvicalyceal dilatation is more on the left side than right side</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e00da3ed",
      "audio": ""
    },
    {
      "text": "A 30y primigravida presents in labor at 38 weeks. The resident notes that she is HBsAg positive. Which of the following statements regarding immunization of a newborn born to a HBsAg positive mother is true?",
      "options": [
        {
          "label": "A",
          "text": "Hep-B Vaccine should be administered within 24 hours of birth",
          "correct": false
        },
        {
          "label": "B",
          "text": "HBIG should be administered within 12 hours of birth.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hep-B Vaccine and HBIG should be administered within 12 hours of birth",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hep-B Vaccine and HBIG should be administered within 24 hours of birth",
          "correct": false
        }
      ],
      "correct_answer": "C. Hep-B Vaccine and HBIG should be administered within 12 hours of birth",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hep-B Vaccine and HBIG should be administered within 12 hours of birth)</strong></p>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Williams Obstetrics 25 th edition Page 1065</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "55d21930",
      "audio": ""
    },
    {
      "text": "Obstetric causes of Acute Kidney Injury (AKI) in pregnancy include all except?",
      "options": [
        {
          "label": "A",
          "text": "Abruptio placenta",
          "correct": false
        },
        {
          "label": "B",
          "text": "Postpartum hemorrhage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute Fatty liver of Pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Antiphospholipid Antibody syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Antiphospholipid Antibody syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Antiphospholipid antibody syndrome</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ecb2ae7",
      "audio": ""
    },
    {
      "text": "Which of the following is incorrect regarding Obstetric Cholestasis?",
      "options": [
        {
          "label": "A",
          "text": "It is the most common cause of jaundice in pregnancy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Itching is typically present on the palms and soles",
          "correct": false
        },
        {
          "label": "C",
          "text": "The recurrence rate in subsequent pregnancies is up to 50%",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is associated with meconium staining of amniotic fluid and fetal death",
          "correct": false
        }
      ],
      "correct_answer": "A. It is the most common cause of jaundice in pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. It is the most common cause of jaundice in pregnancy</strong></p>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference-: Page 1059, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c71ce554",
      "audio": ""
    },
    {
      "text": "A 27-year G2P1L1 presents at 33 weeks with itching mainly on the palms of her hands. The itching worsens at night. She gives a similar history in her 1 st pregnancy. On examination, her BP is 130/84 mmHg. There is mild icterus and abdominal examination reveals a 32 weeks uterus with fetal heart rate of 140 bpm. Her SGOT is 112 IU/L, SGPT is 124 IU/L and serum bilirubin is 2 mg%. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Immediate induction of labor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Emergency LSCS",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monitor BP and plan delivery at 37 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Weekly LFT and plan delivery at 38 weeks",
          "correct": true
        }
      ],
      "correct_answer": "D. Weekly LFT and plan delivery at 38 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Weekly LFT and plan delivery at 38 weeks</strong></p>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: - Williams Obstetrics 25 th edition, Page no 1060</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1a9806e4",
      "audio": ""
    },
    {
      "text": "Liver dysfunction is seen in all of the following in pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Gestational Diabetes",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hyperemesis gravidarum",
          "correct": false
        },
        {
          "label": "C",
          "text": "Obstetric cholestasis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pre-eclampsia",
          "correct": false
        }
      ],
      "correct_answer": "A. Gestational Diabetes",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/screenshot-2023-04-30-144703.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Gestational Diabetes</strong></p>\n<p><strong>References:</strong></p><ul><li>\u21b3 (Reference- Page no 270, DC Dutta\u2019s textbook of Obstetrics, 9 th edition)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a50fe558",
      "audio": ""
    },
    {
      "text": "To define preeclampsia, the proteinuria defined is?",
      "options": [
        {
          "label": "A",
          "text": "\u2265 300 mg/ 24 h",
          "correct": true
        },
        {
          "label": "B",
          "text": "\u2265 30 mg/24 h",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u2265 3 mg/24 h",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u2265 0.3mg/ 24h",
          "correct": false
        }
      ],
      "correct_answer": "A. \u2265 300 mg/ 24 h",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. \u2265 300 mg/ 24 h</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The diagnosis of preeclampsia involves assessing for the presence of hypertension and significant proteinuria, defined as the excretion of 300 mg or more of protein in a 24-hour urine collection.</li><li>\u27a4 Ref: Page no 712, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 712, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d323bba7",
      "audio": ""
    },
    {
      "text": "All are true regarding gestational hypertension except?",
      "options": [
        {
          "label": "A",
          "text": "The diagnosis is made if BP > 140/90 mmHg after 20 weeks in the absence of proteinuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "10% of eclamptic seizures develop in women with gestational hypertension",
          "correct": false
        },
        {
          "label": "C",
          "text": "The diagnosis is made only if the blood pressure does not return to normal after 12 weeks postpartum",
          "correct": true
        },
        {
          "label": "D",
          "text": "It is also known as transient hypertension as the BP returns to normal postpartum",
          "correct": false
        }
      ],
      "correct_answer": "C. The diagnosis is made only if the blood pressure does not return to normal after 12 weeks postpartum",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-184021.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-184135.jpg"
      ],
      "explanation": "<p><strong>Ans. C. The diagnosis is made only if the blood pressure does not return to normal after 12 weeks postpartum</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: page no 711, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 711, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "82f73435",
      "audio": ""
    },
    {
      "text": "Patellar reflexes disappear when the plasma magnesium level reaches:",
      "options": [
        {
          "label": "A",
          "text": "8 mEq/L",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 mEq/L",
          "correct": true
        },
        {
          "label": "C",
          "text": "12 mEq/L",
          "correct": false
        },
        {
          "label": "D",
          "text": "14 mEq/L",
          "correct": false
        }
      ],
      "correct_answer": "B. 10 mEq/L",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 10 mEq/L</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Monitoring for magnesium toxicity is crucial when administering magnesium sulfate, especially in obstetric settings for conditions like preeclampsia or eclampsia. The loss of deep tendon reflexes, such as the patellar reflex, is the first clinical sign and usually occurs at plasma magnesium levels around 10 mEq/L.</li><li>\u27a4 Monitoring for magnesium toxicity is crucial when administering magnesium sulfate, especially in obstetric settings for conditions like preeclampsia or eclampsia.</li><li>\u27a4 The loss of deep tendon reflexes, such as the patellar reflex, is the first clinical sign and usually occurs at plasma magnesium levels around 10 mEq/L.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7be07e12",
      "audio": ""
    },
    {
      "text": "A 25-year-old P2L2 had just delivered following induction for severe preeclampsia. Her BP on the 2 nd postnatal day is 160/100mmHg. Which anti-hypertensive should be avoided in a breastfeeding mother?",
      "options": [
        {
          "label": "A",
          "text": "Amlodipine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Labetalol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Captopril",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nifedipine",
          "correct": false
        }
      ],
      "correct_answer": "A. Amlodipine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Amlodipine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Antihypertensive agents with no known adverse effects on infants receiving breast milk: Mnemonic: ECLAM-N Enalapril Captopril Labetalol Atenolol Metoprolol Nifedipine</li><li>\u27a4 Antihypertensive agents with no known adverse effects on infants receiving breast milk: Mnemonic: ECLAM-N Enalapril Captopril Labetalol Atenolol Metoprolol Nifedipine</li><li>\u27a4 Mnemonic: ECLAM-N</li><li>\u27a4 Enalapril Captopril Labetalol Atenolol Metoprolol Nifedipine</li><li>\u27a4 Enalapril</li><li>\u27a4 Captopril</li><li>\u27a4 Labetalol</li><li>\u27a4 Atenolol</li><li>\u27a4 Metoprolol</li><li>\u27a4 Nifedipine</li><li>\u27a4 Ref: Smith, M , Waugh, J, Nelson\u2010Piercy, C Management of postpartum hypertension The Obstetrician & Gynecologist 2013; 15: 45\u2013 50</li><li>\u27a4 Ref: Smith, M , Waugh, J, Nelson\u2010Piercy, C Management of postpartum hypertension The Obstetrician & Gynecologist 2013; 15: 45\u2013 50</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "13bd07c8",
      "audio": ""
    },
    {
      "text": "A 37-year lady with chronic hypertension visits the gynecologist for pre-conceptional counselling. She is currently taking Telmisartan for her hypertension. Which is the correct statement?",
      "options": [
        {
          "label": "A",
          "text": "Stop Telmisartan 3 months prior to conception and re-start it at the 3 rd month of pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stop Telmisartan 3 months pre-conceptionally and start Labetalol",
          "correct": true
        },
        {
          "label": "C",
          "text": "Continue Telmisartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Continue Telmisartan and add Labetalol if BP is uncontrolled in pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are nor formed and are therefore contra-indicated in pregnancy.</li><li>\u27a4 ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are nor formed and are therefore contra-indicated in pregnancy.</li><li>\u27a4 Ref: Page no 438, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 438, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "82b2881a",
      "audio": ""
    },
    {
      "text": "During a routine antenatal visit, an 24-year G1 at 20 weeks gestational age undergoes a urinalysis. The dipstick done indicates the presence of glycosuria. All other parameters of the urine test are normal. Which of the following is the most likely etiology of sugar detected in the urine?",
      "options": [
        {
          "label": "A",
          "text": "The patient has diabetes",
          "correct": false
        },
        {
          "label": "B",
          "text": "The patient has a urine infection",
          "correct": false
        },
        {
          "label": "C",
          "text": "The patient\u2019s urinalysis is consistent with normal pregnancy",
          "correct": true
        },
        {
          "label": "D",
          "text": "The patient\u2019s urine sample is contaminated.",
          "correct": false
        }
      ],
      "correct_answer": "C. The patient\u2019s urinalysis is consistent with normal pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. The patient\u2019s urinalysis is consistent with normal pregnancy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Physiological glycosuria, a normal response to hormonal changes in pregnancy, may lead to the presence of glucose in the urine without underlying diabetes. It is essential to consider other factors, such as diabetes, urinary tract infections, and sample contamination, and perform further tests if necessary to determine the cause of glycosuria.</li><li>\u27a4 Physiological glycosuria, a normal response to hormonal changes in pregnancy, may lead to the presence of glucose in the urine without underlying diabetes. It is essential to consider other factors, such as diabetes, urinary tract infections, and sample contamination, and perform further tests if necessary to determine the cause of glycosuria.</li><li>\u27a4 Ref: Page 66, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 66, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7248592d",
      "audio": ""
    },
    {
      "text": "Which is NOT seen in gestational diabetes mellitus?",
      "options": [
        {
          "label": "A",
          "text": "Malformations",
          "correct": true
        },
        {
          "label": "B",
          "text": "Polyhydramnios",
          "correct": false
        },
        {
          "label": "C",
          "text": "Obesity",
          "correct": false
        },
        {
          "label": "D",
          "text": "Previous history of macrosomia",
          "correct": false
        }
      ],
      "correct_answer": "A. Malformations",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Malformations</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gestational diabetes mellitus (GDM) is typically not associated with congenital malformations GDM can lead to complications such as polyhydramnios, especially if blood sugar levels are uncontrolled during pregnancy. Obesity is a risk factor for the development of GDM and a previous history of giving birth to a macrosomic baby increases the risk of GDM in subsequent pregnancies.</li><li>\u27a4 Gestational diabetes mellitus (GDM) is typically not associated with congenital malformations</li><li>\u27a4 GDM can lead to complications such as polyhydramnios, especially if blood sugar levels are uncontrolled during pregnancy.</li><li>\u27a4 Obesity is a risk factor for the development of GDM and a previous history of giving birth to a macrosomic baby increases the risk of GDM in subsequent pregnancies.</li><li>\u27a4 Ref:  Page no 1110, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref:  Page no 1110, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "36ad56c7",
      "audio": ""
    },
    {
      "text": "Pederson\u2019s hypothesis states that:",
      "options": [
        {
          "label": "A",
          "text": "Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and related complications",
          "correct": true
        },
        {
          "label": "B",
          "text": "Maternal insulin can cross the placenta resulting in neonatal hypoglycemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maternal hyperglycemia results in an increased incidence of congenital anomalies",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fetal hyperinsulinemia results in a lower incidence of respiratory distress syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and related complications",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-100917.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and related complications.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Pederson's hypothesis emphasizes the direct impact of maternal hyperglycemia on the fetus, leading to fetal hyperglycemia and resultant fetal hyperinsulinemia. This cascade underscores the importance of strict glycemic control in pregnant women with diabetes to prevent fetal complications, including macrosomia, birth injuries, and neonatal hypoglycemia.</li><li>\u27a4 Pederson's hypothesis emphasizes the direct impact of maternal hyperglycemia on the fetus, leading to fetal hyperglycemia and resultant fetal hyperinsulinemia.</li><li>\u27a4 This cascade underscores the importance of strict glycemic control in pregnant women with diabetes to prevent fetal complications, including macrosomia, birth injuries, and neonatal hypoglycemia.</li><li>\u27a4 Ref: Page no 1102, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 1102, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b57f652c",
      "audio": ""
    },
    {
      "text": "A 36-year diabetic woman on insulin is planning conception. She is worried about the risk of fetal congenital anomalies and visits for preconception counseling. Which of the following is the correct statement?",
      "options": [
        {
          "label": "A",
          "text": "Caudal regression syndrome is a commonly associated anomaly seen in diabetes",
          "correct": false
        },
        {
          "label": "B",
          "text": "The risk of anomalies in the fetus is inversely proportional to the level of HBA1c.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Folic acid in a dose of 5 mg/day started in the preconception period will not reduce the risk of neural tube defects.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metformin and Glyburide can be safely continued in pregnancy even though they cross the placenta.",
          "correct": true
        }
      ],
      "correct_answer": "D. Metformin and Glyburide can be safely continued in pregnancy even though they cross the placenta.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Metformin and Glyburide can be safely continued in pregnancy even though they cross the placenta.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 While higher HbA1c levels are associated with increased risks, the use of certain oral hypoglycemic agents like metformin and glyburide is considered safe during pregnancy. Additionally, folic acid supplementation is important for reducing the risk of neural tube defects.</li><li>\u27a4 While higher HbA1c levels are associated with increased risks, the use of certain oral hypoglycemic agents like metformin and glyburide is considered safe during pregnancy.</li><li>\u27a4 Additionally, folic acid supplementation is important for reducing the risk of neural tube defects.</li><li>\u27a4 Ref:  Page no 1110, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref:  Page no 1110, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dcd79e4c",
      "audio": ""
    },
    {
      "text": "A 23-year primigravida presents to the OPD at 24 weeks. She is advised to get a Glucose Challenge Test done. All are true regarding the glucose challenge test (GCT) except?",
      "options": [
        {
          "label": "A",
          "text": "It is done in the fasting state",
          "correct": true
        },
        {
          "label": "B",
          "text": "Patients with a positive GCT are subjected to a GTT",
          "correct": false
        },
        {
          "label": "C",
          "text": "The lower the threshold taken in a GCT, the higher the sensitivity for detection of gestational diabetes mellitus",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is done between 24 \u2013 28 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. It is done in the fasting state",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. It is done in the fasting state.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The Glucose Challenge Test is a non-fasting, initial screening test for gestational diabetes conducted between 24 to 28 weeks of pregnancy. A positive GCT necessitates further testing with a Glucose Tolerance Test. Adjusting the threshold level of the GCT can impact its sensitivity and specificity for detecting gestational diabetes.</li><li>\u27a4 The Glucose Challenge Test is a non-fasting, initial screening test for gestational diabetes conducted between 24 to 28 weeks of pregnancy.</li><li>\u27a4 A positive GCT necessitates further testing with a Glucose Tolerance Test. Adjusting the threshold level of the GCT can impact its sensitivity and specificity for detecting gestational diabetes.</li><li>\u27a4 Ref: Page no 262, DC Dutta's Textbook of Obstetrics 9 th edition</li><li>\u27a4 Ref: Page no 262, DC Dutta's Textbook of Obstetrics 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "30e4f8a8",
      "audio": ""
    },
    {
      "text": "As per IADPSG recommendations, pre-gestational diabetes is diagnosed in the 1 st antenatal visit by all of the values given below except?",
      "options": [
        {
          "label": "A",
          "text": "FBS \u2265 126 mg/dL",
          "correct": false
        },
        {
          "label": "B",
          "text": "PPBS \u2265 140 mg/dl",
          "correct": true
        },
        {
          "label": "C",
          "text": "HbA1C \u2265 6.5 %",
          "correct": false
        },
        {
          "label": "D",
          "text": "RBS \u2265 200 mg/dL",
          "correct": false
        }
      ],
      "correct_answer": "B. PPBS \u2265 140 mg/dl",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. PPBS \u2265 140 mg/dl</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In diagnosing pre-gestational diabetes during the first antenatal visit, IADPSG guidelines include criteria such as a fasting blood sugar of \u2265 126 mg/dL, an HbA1c of \u2265 6.5%, or a random blood sugar of \u2265 200 mg/dL.</li><li>\u27a4 In diagnosing pre-gestational diabetes during the first antenatal visit, IADPSG guidelines include criteria such as a fasting blood sugar of \u2265 126 mg/dL, an HbA1c of \u2265 6.5%, or a random blood sugar of \u2265 200 mg/dL.</li><li>\u27a4 Ref: Page 1108, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 1108, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e6eb16da",
      "audio": ""
    },
    {
      "text": "Target blood glucose levels for women with gestational diabetes on treatment are:",
      "options": [
        {
          "label": "A",
          "text": "FBS < 95 mg/dL, 1h PP < 140 mg/dL, 2h PP < 120 mg/dL",
          "correct": true
        },
        {
          "label": "B",
          "text": "FBS < 90 mg/dl, 1h PP < 145 mg/ dl, 2h < 125 mg/dl",
          "correct": false
        },
        {
          "label": "C",
          "text": "FBS < 105 mg/dl, 1h PP < 140 mg/dl, 2h PP < 120 mg/dl",
          "correct": false
        },
        {
          "label": "D",
          "text": "FBS < 95 mg/dl, 1h PP < 120 mg/ dl, 2h PP < 140 mg/dl",
          "correct": false
        }
      ],
      "correct_answer": "A. FBS < 95 mg/dL, 1h PP < 140 mg/dL, 2h PP < 120 mg/dL",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.\u00a0 FBS < 95 mg/dL, 1h PP < 140 mg/dL, 2h PP < 120 mg/dL</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For the management of gestational diabetes, target blood glucose levels are set to ensure both maternal and fetal well-being. The recommended targets are: fasting blood sugar less than 95 mg/dL 1-hour postprandial less than 140 mg/dL 2-hour postprandial less than 120 mg/dL.</li><li>\u27a4 For the management of gestational diabetes, target blood glucose levels are set to ensure both maternal and fetal well-being. The recommended targets are: fasting blood sugar less than 95 mg/dL 1-hour postprandial less than 140 mg/dL 2-hour postprandial less than 120 mg/dL.</li><li>\u27a4 fasting blood sugar less than 95 mg/dL 1-hour postprandial less than 140 mg/dL 2-hour postprandial less than 120 mg/dL.</li><li>\u27a4 fasting blood sugar less than 95 mg/dL</li><li>\u27a4 1-hour postprandial less than 140 mg/dL</li><li>\u27a4 2-hour postprandial less than 120 mg/dL.</li><li>\u27a4 Ref: Page no 264, DC Dutta\u2019s Textbook of Obstetrics 9 th edition</li><li>\u27a4 Ref: Page no 264, DC Dutta\u2019s Textbook of Obstetrics 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a12429a1",
      "audio": ""
    },
    {
      "text": "All the following precautions are taken in labor in a woman with pre-eclampsia except?",
      "options": [
        {
          "label": "A",
          "text": "Cut short the 2 nd stage of labor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prophylactic methylergometrine at the delivery of anterior shoulder",
          "correct": true
        },
        {
          "label": "C",
          "text": "Restrict IV fluids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxytocin 10U IM following delivery",
          "correct": false
        }
      ],
      "correct_answer": "B. Prophylactic methylergometrine at the delivery of anterior shoulder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Prophylactic methylergometrine at the delivery of anterior shoulder</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Precautions to be taken in labor in women with pre-eclampsia</li><li>\u27a4 Restrict IV fluids to avoid pulmonary edema Cut short 2 nd stage of labor using instrumental delivery Avoid methylergometrine at delivery of anterior shoulder Active management of 3 rd stage of labor including Oxytocin 10IU IM</li><li>\u27a4 Restrict IV fluids to avoid pulmonary edema</li><li>\u27a4 Cut short 2 nd stage of labor using instrumental delivery</li><li>\u27a4 Avoid methylergometrine at delivery of anterior shoulder</li><li>\u27a4 Active management of 3 rd stage of labor including Oxytocin 10IU IM</li><li>\u27a4 Ref: page no 440, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li><li>\u27a4 Ref: page no 440, Textbook of Obstetrics, Dr JB Sharma 1 st edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f90990c",
      "audio": ""
    },
    {
      "text": "All of the following indicate superimposed pre-eclampsia in a pregnant female of chronic hypertension except:",
      "options": [
        {
          "label": "A",
          "text": "New onset proteinuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Platelet count < 75,000",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fresh retinal hypertensive changes",
          "correct": false
        }
      ],
      "correct_answer": "C. Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-192932.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-193029.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: Page no 1780, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 1780, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e63fdf76",
      "audio": ""
    },
    {
      "text": "Elective cesarean delivery is indicated in a diabetic woman if the estimated fetal weight is",
      "options": [
        {
          "label": "A",
          "text": "> 4000g",
          "correct": false
        },
        {
          "label": "B",
          "text": "> 4500g",
          "correct": true
        },
        {
          "label": "C",
          "text": "> 5000g",
          "correct": false
        },
        {
          "label": "D",
          "text": "> 5500g",
          "correct": false
        }
      ],
      "correct_answer": "B. > 4500g",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. > 4500g</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 As per ACOG, for diabetic pregnant women, an elective cesarean delivery is recommended if the estimated fetal weight exceeds 4.5 kg. This is in contrast to non-diabetic women, where the threshold for an elective cesarean is set at an estimated fetal weight of more than 5 kg. The lower threshold for diabetic women is due to the increased risk of macrosomia and related birth complications, including shoulder dystocia.</li><li>\u27a4 As per ACOG, for diabetic pregnant women, an elective cesarean delivery is recommended if the estimated fetal weight exceeds 4.5 kg.</li><li>\u27a4 This is in contrast to non-diabetic women, where the threshold for an elective cesarean is set at an estimated fetal weight of more than 5 kg.</li><li>\u27a4 The lower threshold for diabetic women is due to the increased risk of macrosomia and related birth complications, including shoulder dystocia.</li><li>\u27a4 Ref: Page 859, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 859, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3a4bfb0f",
      "audio": ""
    },
    {
      "text": "A pregnant woman is diagnosed with primary genital herpes infection. What is the most appropriate management regarding delivery?",
      "options": [
        {
          "label": "A",
          "text": "Elective cesarean delivery regardless of the presence of lesions at the time of labor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vaginal delivery if there are no active lesions at the time of labor",
          "correct": true
        },
        {
          "label": "C",
          "text": "Vaginal delivery with administration of antiviral prophylaxis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Induction of labor at 37 weeks to reduce the risk of neonatal infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Vaginal delivery if there are no active lesions at the time of labor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Vaginal delivery if there are no active lesions at the time of labor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 .</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 If there is active genital herpes at term, cesarean section has to be done</li><li>\u27a4 If there is active genital herpes at term, cesarean section has to be done</li><li>\u27a4 Ref: Page no 673, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5 th edition</li><li>\u27a4 Ref: Page no 673, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d818818",
      "audio": ""
    },
    {
      "text": "A multiparous patient who did not attend any antenatal visit and came to causality with complaint of bleeding. On examination uterine tone was increased with BP>144/92 mmHg. Which of the following tests supports the diagnosis of preeclampsia?",
      "options": [
        {
          "label": "A",
          "text": "Creatinine levels 1.24mg/dl",
          "correct": true
        },
        {
          "label": "B",
          "text": "Platelet counts 154000/microL",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alkaline phosphatase 142 IU/L",
          "correct": false
        },
        {
          "label": "D",
          "text": "Total protein of 252mg in a 24-hour urine collection",
          "correct": false
        }
      ],
      "correct_answer": "A. Creatinine levels 1.24mg/dl",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Creatinine levels 1.24mg/dl</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Preeclampsia Definitions</li><li>\u27a4 Preeclampsia</li><li>\u27a4 Preeclampsia</li><li>\u27a4 Hypertension and proteinuria or In absence of proteinuria, new-onset hypertension with the new onset of any of the following Thrombocytopenia: Platelets <100 x 10 9 /L Renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease Impaired liver function: Elevated blood concentrations of liver transaminases to twice normal concentration Pulmonary edema Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 Hypertension and proteinuria or</li><li>\u27a4 or</li><li>\u27a4 In absence of proteinuria, new-onset hypertension with the new onset of any of the following Thrombocytopenia: Platelets <100 x 10 9 /L Renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease Impaired liver function: Elevated blood concentrations of liver transaminases to twice normal concentration Pulmonary edema Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 Thrombocytopenia: Platelets <100 x 10 9 /L Renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease Impaired liver function: Elevated blood concentrations of liver transaminases to twice normal concentration Pulmonary edema Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 Thrombocytopenia: Platelets <100 x 10 9 /L</li><li>\u27a4 Renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease</li><li>\u27a4 Impaired liver function: Elevated blood concentrations of liver transaminases to twice normal concentration</li><li>\u27a4 Pulmonary edema</li><li>\u27a4 Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 or</li><li>\u27a4 Preeclampsia with severe features</li><li>\u27a4 Preeclampsia with severe features</li><li>\u27a4 Preeclampsia diagnosis, above, with any of the following Severe hypertension On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy) Thrombocytopenia: Platelets <100 x 10 9 /L Impaired liver function (without an alternative diagnosis): Elevated liver transaminases greater than twice upper limit of normal or severe persistent right upper quadrant or epigastric pain not responsive to medications Progressive renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease Pulmonary edema Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 Preeclampsia diagnosis, above, with any of the following Severe hypertension On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy) Thrombocytopenia: Platelets <100 x 10 9 /L Impaired liver function (without an alternative diagnosis): Elevated liver transaminases greater than twice upper limit of normal or severe persistent right upper quadrant or epigastric pain not responsive to medications Progressive renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease Pulmonary edema Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 Severe hypertension On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy) Thrombocytopenia: Platelets <100 x 10 9 /L Impaired liver function (without an alternative diagnosis): Elevated liver transaminases greater than twice upper limit of normal or severe persistent right upper quadrant or epigastric pain not responsive to medications Progressive renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease Pulmonary edema Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 Severe hypertension On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy)</li><li>\u27a4 On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy)</li><li>\u27a4 On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy)</li><li>\u27a4 Thrombocytopenia: Platelets <100 x 10 9 /L</li><li>\u27a4 Impaired liver function (without an alternative diagnosis): Elevated liver transaminases greater than twice upper limit of normal or severe persistent right upper quadrant or epigastric pain not responsive to medications</li><li>\u27a4 or</li><li>\u27a4 or</li><li>\u27a4 Progressive renal insufficiency: serum creatinine >1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease</li><li>\u27a4 Pulmonary edema</li><li>\u27a4 Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis) or visual symptoms</li><li>\u27a4 or</li><li>\u27a4 Note: The following are not diagnostic criteria for the diagnosis of preeclampsia or preeclampsia with severe features</li><li>\u27a4 Note:</li><li>\u27a4 Clinically evident edema Rapid weight gain Massive proteinuria Does not qualify as a \u2018severe feature\u2019 Fetal growth restriction Expectant management \u2018may be reasonable\u2019 if mother and fetus appear stable and no other clinical indication is present that would indicate the need for early delivery ACOG states that while it is important to monitor fetal status, FGR in the setting of all other fetal assessment being within normal limits (e.g., AFV, Doppler) Uric acid Hyperuricemia in hypertensive pregnancy is not a diagnostic marker, but is an important finding as a risk factor for adverse maternal and fetal outcomes Small for gestational age (SGA) infant Prematurity Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid May be warranted in the setting of \u2018diagnostic dilemmas\u2019 such as diagnosing superimposed preeclampsia in the setting of chronic hypertension</li><li>\u27a4 Clinically evident edema</li><li>\u27a4 Rapid weight gain</li><li>\u27a4 Massive proteinuria Does not qualify as a \u2018severe feature\u2019</li><li>\u27a4 Does not qualify as a \u2018severe feature\u2019</li><li>\u27a4 Does not qualify as a \u2018severe feature\u2019</li><li>\u27a4 Fetal growth restriction Expectant management \u2018may be reasonable\u2019 if mother and fetus appear stable and no other clinical indication is present that would indicate the need for early delivery ACOG states that while it is important to monitor fetal status, FGR in the setting of all other fetal assessment being within normal limits (e.g., AFV, Doppler)</li><li>\u27a4 Expectant management \u2018may be reasonable\u2019 if mother and fetus appear stable and no other clinical indication is present that would indicate the need for early delivery ACOG states that while it is important to monitor fetal status, FGR in the setting of all other fetal assessment being within normal limits (e.g., AFV, Doppler)</li><li>\u27a4 Expectant management \u2018may be reasonable\u2019 if mother and fetus appear stable and no other clinical indication is present that would indicate the need for early delivery ACOG states that while it is important to monitor fetal status, FGR in the setting of all other fetal assessment being within normal limits (e.g., AFV, Doppler)</li><li>\u27a4 Uric acid Hyperuricemia in hypertensive pregnancy is not a diagnostic marker, but is an important finding as a risk factor for adverse maternal and fetal outcomes Small for gestational age (SGA) infant Prematurity Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid May be warranted in the setting of \u2018diagnostic dilemmas\u2019 such as diagnosing superimposed preeclampsia in the setting of chronic hypertension</li><li>\u27a4 Hyperuricemia in hypertensive pregnancy is not a diagnostic marker, but is an important finding as a risk factor for adverse maternal and fetal outcomes Small for gestational age (SGA) infant Prematurity Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid May be warranted in the setting of \u2018diagnostic dilemmas\u2019 such as diagnosing superimposed preeclampsia in the setting of chronic hypertension</li><li>\u27a4 Hyperuricemia in hypertensive pregnancy is not a diagnostic marker, but is an important finding as a risk factor for adverse maternal and fetal outcomes Small for gestational age (SGA) infant Prematurity Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid</li><li>\u27a4 Small for gestational age (SGA) infant Prematurity Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid</li><li>\u27a4 Small for gestational age (SGA) infant</li><li>\u27a4 Prematurity</li><li>\u27a4 Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid</li><li>\u27a4 May be warranted in the setting of \u2018diagnostic dilemmas\u2019 such as diagnosing superimposed preeclampsia in the setting of chronic hypertension</li><li>\u27a4 Ref: https://www.preeclampsia.org/frontend/assets/img/advocacy_resource/Gestational_Hypertension_and_Preeclampsia_ACOG_Practice_Bulletin,_Number_222_1605448006.pdf</li><li>\u27a4 Ref:</li><li>\u27a4 https://www.preeclampsia.org/frontend/assets/img/advocacy_resource/Gestational_Hypertension_and_Preeclampsia_ACOG_Practice_Bulletin,_Number_222_1605448006.pdf</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f608f6f",
      "audio": ""
    },
    {
      "text": "The highest risk of developing congenital varicella syndrome is?",
      "options": [
        {
          "label": "A",
          "text": "6-10 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "12-20 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "24-28 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "36 \u2013 40 weeks",
          "correct": false
        }
      ],
      "correct_answer": "B. 12-20 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 12-20 weeks</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "64f0c76a",
      "audio": ""
    },
    {
      "text": "A 25 y woman is planning to conceive. She is unsure of her childhood vaccination status. Which of the following vaccines should she receive before conceiving?",
      "options": [
        {
          "label": "A",
          "text": "CMV",
          "correct": false
        },
        {
          "label": "B",
          "text": "HPV",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rubella",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tetanus",
          "correct": false
        }
      ],
      "correct_answer": "C. Rubella",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Rubella</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e8edb93",
      "audio": ""
    },
    {
      "text": "A 24-year G2P1L1 teacher presents at 22 weeks with fever and rash since 2 days. She gives history of contact with a child in her class who had chicken pox 10 days earlier. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Consider termination of pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral Acyclovir, antipyretics, and hydration",
          "correct": true
        },
        {
          "label": "C",
          "text": "IV Acyclovir",
          "correct": false
        },
        {
          "label": "D",
          "text": "Varicella Zoster Immunoglobulin (VZIG)",
          "correct": false
        }
      ],
      "correct_answer": "B. Oral Acyclovir, antipyretics, and hydration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Oral Acyclovir, antipyretics, and hydration</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bff2a912",
      "audio": ""
    },
    {
      "text": "Which of the following infections can cause fetal hydrops?",
      "options": [
        {
          "label": "A",
          "text": "Malaria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Parvovirus",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rubella",
          "correct": false
        },
        {
          "label": "D",
          "text": "Varicella",
          "correct": false
        }
      ],
      "correct_answer": "B. Parvovirus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Parvovirus</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ae4325eb",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman in her first trimester presents with fever, rash, and arthralgia. She recently returned from a trip to a region where Zika virus is endemic. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Reassure and advise symptomatic treatment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prescribe antibiotics",
          "correct": false
        },
        {
          "label": "C",
          "text": "Order Zika virus testing",
          "correct": true
        },
        {
          "label": "D",
          "text": "Initiate antiviral therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Order Zika virus testing",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Order Zika virus testing</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Zika virus in pregnancy</li><li>\u27a4 Zika virus in pregnancy</li><li>\u27a4 This RNA flavivirus is the first major mosquito-borne teratogen recognized Zika virus is primarily transmitted by mosquito bite, but sexual transmission is possible. Maternal-Fetal Infection: Zika infection is asymptomatic in approximately 80 percent of adults. It may cause mild rash, fever, headache, arthralgia, and conjunctivitis lasting a few days. The fetus can be severely infected whether the mother is symptomatic. In the most severely affected fetuses, a congenital Zika syndrome has been described that includes microcephaly, lissencephaly, ventriculomegaly, intracranial calcifications, ocular abnormalities, and congenital contractures Diagnosis and Management. Laboratory testing for Zika infection is recommended in symptomatic gravidas with residence in or recent travel to areas with active dengue transmission and risk for Zika transmission Serum IgM antibodies typically become detectable within the first 2 weeks and may persist for months. For a pregnant woman within 12 weeks of symptom onset, PCR testing of serum and urine specimens for both dengue and Zika virus RNA is recommended. For women with prenatal ultrasound findings suggesting congenital Zika syndrome, Zika virus PCR and IgM are initially performed on serum and urine. Amnionic fluid PCR may be performed, although less is known about its diagnostic accuracy for congenital infection. Currently, no specific treatment or vaccine is available for Zika infection, although several vaccines are in development</li><li>\u27a4 This RNA flavivirus is the first major mosquito-borne teratogen recognized</li><li>\u27a4 Zika virus is primarily transmitted by mosquito bite, but sexual transmission is possible.</li><li>\u27a4 Maternal-Fetal Infection: Zika infection is asymptomatic in approximately 80 percent of adults. It may cause mild rash, fever, headache, arthralgia, and conjunctivitis lasting a few days. The fetus can be severely infected whether the mother is symptomatic. In the most severely affected fetuses, a congenital Zika syndrome has been described that includes microcephaly, lissencephaly, ventriculomegaly, intracranial calcifications, ocular abnormalities, and congenital contractures</li><li>\u27a4 Zika infection is asymptomatic in approximately 80 percent of adults. It may cause mild rash, fever, headache, arthralgia, and conjunctivitis lasting a few days. The fetus can be severely infected whether the mother is symptomatic. In the most severely affected fetuses, a congenital Zika syndrome has been described that includes microcephaly, lissencephaly, ventriculomegaly, intracranial calcifications, ocular abnormalities, and congenital contractures</li><li>\u27a4 Zika infection is asymptomatic in approximately 80 percent of adults.</li><li>\u27a4 It may cause mild rash, fever, headache, arthralgia, and conjunctivitis lasting a few days.</li><li>\u27a4 The fetus can be severely infected whether the mother is symptomatic.</li><li>\u27a4 In the most severely affected fetuses, a congenital Zika syndrome has been described that includes microcephaly, lissencephaly, ventriculomegaly, intracranial calcifications, ocular abnormalities, and congenital contractures</li><li>\u27a4 Diagnosis and Management. Laboratory testing for Zika infection is recommended in symptomatic gravidas with residence in or recent travel to areas with active dengue transmission and risk for Zika transmission Serum IgM antibodies typically become detectable within the first 2 weeks and may persist for months. For a pregnant woman within 12 weeks of symptom onset, PCR testing of serum and urine specimens for both dengue and Zika virus RNA is recommended. For women with prenatal ultrasound findings suggesting congenital Zika syndrome, Zika virus PCR and IgM are initially performed on serum and urine. Amnionic fluid PCR may be performed, although less is known about its diagnostic accuracy for congenital infection.</li><li>\u27a4 Laboratory testing for Zika infection is recommended in symptomatic gravidas with residence in or recent travel to areas with active dengue transmission and risk for Zika transmission Serum IgM antibodies typically become detectable within the first 2 weeks and may persist for months. For a pregnant woman within 12 weeks of symptom onset, PCR testing of serum and urine specimens for both dengue and Zika virus RNA is recommended. For women with prenatal ultrasound findings suggesting congenital Zika syndrome, Zika virus PCR and IgM are initially performed on serum and urine. Amnionic fluid PCR may be performed, although less is known about its diagnostic accuracy for congenital infection.</li><li>\u27a4 Laboratory testing for Zika infection is recommended in symptomatic gravidas with residence in or recent travel to areas with active dengue transmission and risk for Zika transmission</li><li>\u27a4 Serum IgM antibodies typically become detectable within the first 2 weeks and may persist for months.</li><li>\u27a4 For a pregnant woman within 12 weeks of symptom onset, PCR testing of serum and urine specimens for both dengue and Zika virus RNA is recommended.</li><li>\u27a4 For women with prenatal ultrasound findings suggesting congenital Zika syndrome, Zika virus PCR and IgM are initially performed on serum and urine. Amnionic fluid PCR may be performed, although less is known about its diagnostic accuracy for congenital infection.</li><li>\u27a4 Currently, no specific treatment or vaccine is available for Zika infection, although several vaccines are in development</li><li>\u27a4 Ref: Williams Textbook of Obstetrics 26 th edition pg 3107</li><li>\u27a4 Ref: Williams Textbook of Obstetrics 26 th edition pg 3107</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b432db5",
      "audio": ""
    }
  ]
}